BROWN & BROWN, INC.
At today's price, BROWN & BROWN, INC. (BRO) is priced for +5.1% earnings growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
At about $59, Brown & Brown trades near 19 times earnings, an earnings yield of roughly 5.2%. Inverted, the price asks for only about 1.9% annual fee-earnings growth, a pace that sits within the firm's own record and in the lower half of its insurance-broker peer group. The demand baked into the price is modest, not heroic. The first quarter of 2026 told two stories at once: total revenue jumped about 35% to $1.9 billion on the Accession acquisition, while organic revenue was flat year over yea
Is BRO overvalued? See what's priced in →
787 institutional managers reported holding BRO in 13F filings for the quarter ended 2026-03-31. Together they hold about 82% of the company; the top 10 hold 45%. 83 opened new positions that quarter. Held by Vanguard Group, BlackRock, Capital Group (American Funds), among others. On the short side, 16.8M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (5.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
BRO's share count grew 20.1% over the past five years even with $325.34M spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $0.62 a share annually. Cash returned over the past three years: $473.80M in dividends and $250.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at BRO over the trailing three years: 2025: 2 buys totaling $341k; 2026: 1 buy totaling $50k. 22 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
BRO's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | +1.8% | -1.1% |
| 2023-10-27 | +3.8% | +5.2% |
| 2024-02-23 | +1.6% | -3.3% |
| 2024-04-25 | +0.9% | +9.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
BRO's latest 8-K filings: 2026-06-05 (items 1.01, 2.03); 2026-05-07 (items 5.02, 5.07); 2026-04-27 (items 2.02, 9.01); 2026-04-09 (items 7.01, 9.01); 2026-03-04 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.